Which one is not an indication for morbid obesity surgery: American Society of Anesthesiologists (ASA) Score 4 patient, Body Mass Index (BMI) greater than 40, BMI greater than 35 with obesity-related morbidity, or BMI greater than 40 with type 2 diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ASA Score 4 is Not an Indication for Morbid Obesity Surgery

An American Society of Anesthesiologists (ASA) Score of 4 is not an indication for morbid obesity surgery, as it actually represents a significant contraindication due to the high perioperative risk. 1

Established Indications for Bariatric Surgery

The established indications for bariatric surgery include:

  • BMI ≥40 kg/m² regardless of comorbidities 1, 2
  • BMI ≥35 kg/m² with at least one obesity-related comorbidity (such as type 2 diabetes, hypertension, hyperlipidemia, obstructive sleep apnea) 1, 3
  • BMI ≥30 kg/m² with type 2 diabetes that could potentially go into remission (lower threshold indication) 1

Understanding ASA Score 4

An ASA Score of 4 indicates a patient with:

  • Severe systemic disease that is a constant threat to life 4
  • Significant cardiac, pulmonary, hepatic, renal, or endocrine dysfunction that severely limits daily activities 4
  • High risk for perioperative complications and mortality 4

Why ASA Score 4 Contraindicates Bariatric Surgery

  • Bariatric surgery requires patients to have acceptable operative risks, which ASA 4 patients do not have 3
  • The American College of Cardiology recommends comprehensive medical evaluation to assess obesity-related comorbidities and surgical risk before bariatric surgery 1
  • Patients with severe systemic disease (ASA 4) have significantly increased perioperative mortality risk that may outweigh potential benefits of bariatric surgery 4

Other Considerations in Bariatric Surgery Candidacy

Beyond BMI criteria, other important considerations include:

  • Failure of non-surgical weight loss methods (structured diet, physical activity, behavioral therapy, pharmacotherapy) 1
  • Patient motivation and ability to comply with long-term treatment and follow-up 1
  • Comprehensive pre-surgical medical, nutritional, and psychological evaluation 1

Special Populations and Considerations

  • For patients with obesity and decompensated cirrhosis, bariatric surgery should only be considered at the time of liver transplantation or thereafter 2
  • Sleeve gastrectomy is the preferred technique for selected patients with obesity and well-compensated cirrhosis 2
  • Lower BMI thresholds should be applied for Asian populations due to different body composition and risk profiles 1

Potential Benefits of Bariatric Surgery

When performed in appropriate candidates, bariatric surgery can result in:

  • Significant and sustained weight loss 2
  • Improvement or resolution of obesity-related comorbidities 2, 1
  • Reduced risk of some malignancies 1
  • Potential improvements in quality of life 2

Potential Risks and Complications

  • Surgical complications (infection, bleeding, anastomotic leaks) 1
  • Nutritional deficiencies requiring lifelong supplementation 1
  • Suboptimal clinical response or weight regain 1
  • Increased perioperative mortality in high-risk patients (such as those with ASA 4) 4

In conclusion, while BMI ≥40, BMI ≥35 with comorbidities, and BMI ≥30 with diabetes are established indications for bariatric surgery, an ASA Score of 4 represents a significant contraindication rather than an indication due to unacceptably high surgical risk.

References

Guideline

Bariatric Surgery Indications and Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Surgical intervention for the severely obese.

Bailliere's best practice & research. Clinical endocrinology & metabolism, 1999

Guideline

Bariatric Specialist Referral for Patient with Morbid Obesity and Multiple Comorbidities

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.